Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada ; volume:19 ; number:1 ; day:21 ; month:11 ; year:2019 ; pages:1-10 ; date:12.2019
BMC infectious diseases ; 19, Heft 1 (21.11.2019), 1-10, 12.2019
- Urheber
-
Rana, Urvi
Driedger, Matt
Sereda, Paul
Pan, Shenyi
Ding, Erin
Wong, Alex
Walmsley, Sharon
Klein, Marina
Kelly, Deborah
Loutfy, Mona
Thomas, Rejean
Sanche, Stephen
Kroch, Abigail
Machouf, Nima
Roy-Gagnon, Marie-Helene
Hogg, Robert
Cooper, Curtis L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-019-4617-8
- URN
-
urn:nbn:de:101:1-2020032300481145569703
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rana, Urvi
- Driedger, Matt
- Sereda, Paul
- Pan, Shenyi
- Ding, Erin
- Wong, Alex
- Walmsley, Sharon
- Klein, Marina
- Kelly, Deborah
- Loutfy, Mona
- Thomas, Rejean
- Sanche, Stephen
- Kroch, Abigail
- Machouf, Nima
- Roy-Gagnon, Marie-Helene
- Hogg, Robert
- Cooper, Curtis L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Liver damage in HIV+HBV co-infected patients determined by transient elastography
Transmission of Hepatitis B virus (HBV) minor variants in children born to HBV/HIV co-infected mothers
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
High prevalence of genotype G in HIV co-infected patients compared with HBV monoinfected patients in México
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Liver damage in HIV+HBV co-infected patients determined by transient elastography
Transmission of Hepatitis B virus (HBV) minor variants in children born to HBV/HIV co-infected mothers
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
High prevalence of genotype G in HIV co-infected patients compared with HBV monoinfected patients in México
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Liver damage in HIV+HBV co-infected patients determined by transient elastography
Transmission of Hepatitis B virus (HBV) minor variants in children born to HBV/HIV co-infected mothers
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons